Align Technology stock holds near USD 150 as analysts back upside
Published on 09/18/2026 at 12:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Align Technology stock (ISIN US0162551016) ended Nasdaq trading at USD 149.71 on September 17, 2026, essentially flat versus the prior close after a 2.4 percent gain in the previous session. The move leaves the share price well below a fresh analyst target, giving investors a clearer view of the current risk-reward profile.
Analysts reaffirm upside for Align Technology
Analyst support has recently underpinned sentiment toward Align Technology stock. According to The Globe and Mail on September 17, 2026, Piper Sandler analyst Jason Bednar maintained a Buy rating on Align Technology and set a price target of USD 235.00 per share. This implies a potential upside of around 57 percent from the September 17, 2026 closing level of USD 149.71 on Nasdaq.
The same report notes that the broader analyst consensus on Align Technology stands at Moderate Buy, with a consensus price target of USD 213.44.The Globe and Mail This consensus figure sits roughly 43 percent above the recent Nasdaq close, giving investors a second reference point for how the market currently values the company’s earnings power and growth prospects.
Stock price and recent trading range on Nasdaq
Per data on the Nasdaq listing view through a financial portal, Align Technology stock traded at USD 149.71 at the close on Nasdaq on September 17, 2026, a decline of 0.49 percent from the prior closing price.Yahoo Finance The prior close was USD 150.45 on September 16, 2026, when the shares gained 2.4 percent compared with the previous day, closing up from USD 147.95 in Nasdaq trading.Ad-hoc corporate news This short-term pattern shows that the stock has recently recovered from levels below USD 150, but still trades significantly under both individual and consensus analyst targets.
While the latest week-filtered search results do not carry a fresh update on the company’s 52-week high or low, the current analyst targets themselves provide a numerical yardstick for the stock’s position. With the Piper Sandler target of USD 235.00 about USD 85 above the September 17, 2026 close, investors can quantify the gap between where the stock trades today and where at least one major analyst expects it could move over the medium term.The Globe and Mail
Fundamental backdrop from the latest reported results
The most recent detailed quarterly figures for Align Technology do not appear within the last-seven-day search window, but the analyst commentary assumes a still-growing business in clear aligners and digital orthodontics. Historically, Align Technology has reported double-digit year-on-year revenue growth in its latest fiscal periods, driven by expanding Invisalign case volumes and uptake of its iTero intraoral scanners. In its most recently reported fiscal year, which ended within the last 24 months relative to September 18, 2026, the company generated revenue in the multi-billion dollar range and maintained healthy operating margins, although exact figures from that report are not repeated in the current week-filtered sources.
For investors, the key fundamental driver now is whether Align Technology can continue to grow clear aligner case volumes and maintain margins amid competition and macroeconomic uncertainty. The consensus price target of USD 213.44 assumes that the company will preserve or improve its profitability profile compared with the latest reported year, while expanding revenue further.The Globe and Mail From a fundamental standpoint, this implies expectations for continued growth in orthodontist adoption and consumer demand for teeth-straightening solutions, as well as ongoing investment in digital tools for treatment planning.
A potential risk highlighted indirectly by the current pricing is valuation. With the stock still trading near USD 150 and analysts projecting substantial upside, any disappointment in revenue growth or margins in the next quarterly report could trigger volatility. Conversely, if upcoming results confirm sustained growth in revenue and earnings per share versus the prior year’s comparable quarter, the gap between current price and targets could narrow over time.
Upcoming catalysts and investor perspective
The next major catalyst for Align Technology stock will likely be its upcoming quarterly earnings release and any updated guidance, although a precise future date for the next report is not explicitly named in the week-filtered sources. Typically, the company reports results on a regular quarterly schedule and updates its outlook for revenue and margins across segments. Investors will be watching closely for numbers that either support or challenge the current analyst targets, particularly revenue growth in core orthodontic markets and profitability trends.
From an investor perspective, the quantified gap between the September 17, 2026 Nasdaq close at USD 149.71 and the Piper Sandler price target of USD 235.00 serves as a concrete reference for potential return if the bullish scenario plays out.The Globe and Mail At the same time, the stock’s recent 2.4 percent daily gain on September 16, 2026 illustrates how quickly sentiment can shift when investors reposition around perceived growth prospects.Ad-hoc corporate news For now, Align Technology stock remains below both individual and consensus targets, with upcoming results likely to determine whether analysts adjust their views.
Align Technology stock price snapshot
Align Technology stock is referenced at a closing price of USD 149.71 on Nasdaq as of September 17, 2026, following a prior close of USD 150.45 on September 16, 2026 in USD terms.Yahoo Finance This recent trading band around USD 150 frames the stock’s current level against analyst expectations and sets the stage for the next move once new fundamental data become available.
Align Technology stock key data
- Company: Align Technology Inc.
- ISIN: US0162551016
- Ticker: ALGN
- Trading venue: Nasdaq
- Price (as of September 17, 2026 16:00): 149.71 USD
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
